Search
Amneal Pharmaceuticals Inc
AMRXAdd to Watchlist
16.210USD
-0.070-0.43%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
5.10BMarket Cap
41.81P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Amneal Pharmaceuticals Inc is 8.00, ranking 55 out of 157 in the Pharmaceuticals industry. The average price target is 13.50, with a high of 15.00 and a low of 13.00.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
17.250
Target Price
+6.42%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Amneal Pharmaceuticals Inc
AMRX
4
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Amneal Pharmaceuticals Inc's expected revenue for the next quarter?
Amneal Pharmaceuticals Inc's expected revenue is 760.56M.
What is Amneal Pharmaceuticals Inc's price target?
Analysts forecast that Amneal Pharmaceuticals Inc's price target is USD 13.50, with the highest forecast at USD 15.00 and the lowest forecast at USD 13.00.
How have Amneal Pharmaceuticals IncAMRX's recent earnings per share performed?
The market expectation was USD 0.20, while Amneal Pharmaceuticals IncAMRX's earnings per share (EPS) for the previous quarter was USD 0.11. EPS for the next quarter is expected at USD 0.22.
What is the analyst rating for Amneal Pharmaceuticals Inc?
Based on the ratings of Amneal Pharmaceuticals Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
